Drug laws fail to protect children

Writes former President of Brazil, Fernando Henrique Cardoso in Elsevier's International Journal of Drug Policy

2011-11-23

(Press-News.org) Amsterdam -- "Would legal regulation and control of drugs better protect children?" is a question posed by former President of Brazil, Fernando Henrique Cardoso in an editorial to be published in the January issue of Elsevier's International Journal of Drug Policy (IJDP).

The editorial, "Children and drug law reform" follows the March 2011 report of the Global Commission on Drug Policy, chaired by Cardoso, which made a series of recommendations for reforms of drug laws, including experiments with legal regulation and control.

"If we believe that the best interests of the child should be a primary consideration in all policies that affect them, as enshrined in the UN Convention on the Rights of the Child, then children have the right to be placed front and centre in drug policy discussions", writes the former president.

Recognising the harms that have befallen children and young people around the world due to drugs prohibition, and the failure of current approaches to protect children from drug use and drug related harms, Cardoso calls for debate on a range of issues including what legal regulation and control of drugs would mean for children.

"I am convinced that the recommendations of the Global Commission will have significant benefits for children and young people," he writes, "I would not support such policies if I did not believe that current approaches have singularly failed in this respect."

But the former president urges caution in relation to possible future business interests in currently illicit drugs. "Our experiences with alcohol and tobacco show that we cannot entrust such commodities to corporations whose interests are in profit maximisation not public health. We cannot relinquish drugs to the criminal market, nor to an unregulated free market."

"To protect children from drugs it is to my mind now beyond debate that drug laws need to be reformed. From what we already know, the ongoing and future identified harms of current drug policies to our children must be considered not as unintended, but a result of negligence, recklessness or simple disregard," concludes Cardoso.

"President Cardoso's editorial is a challenge to politicians, researchers and activists and is a much needed contribution to an important part of the drug policy debate we all too often overlook", said Professor Gerry Stimson, Editor-in-Chief of the International Journal of Drug Policy. "This is no doubt a very difficult and controversial area and I wholeheartedly agree with President Cardoso, we need to create an environment where it is safer to openly discuss these issues."

### Notes to editors Editorial: "Children and drug law reform"; Cardoso, F.H.; International Journal of Drug Policy (2011); doi:10.1016/j.drugpo.2011.10.004. Fernando Henrique Cardoso was President of Brazil from 1995-2002. He is chair of the Global Commission on Drug Policy. The Global Commission on Drug Policy's report is available at http://www.globalcommissionondrugs.org/

About the International Journal of Drug Policy The International Journal of Drug Policy provides a forum for the dissemination of current research, reviews, debate, and critical analysis on drug use and drug policy in a global context. It seeks to publish material on the social, political, legal, and health contexts of psychoactive substance use, both licit and illicit. The journal is particularly concerned to explore the effects of drug policy and practice on drug-using behaviour and its health and social consequences. It is the policy of the journal to represent a wide range of material on drug-related matters from around the world. For more information go to: http://www.ijdp.org

About Elsevier Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including the Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect, SciVerse Scopus, Reaxys, MD Consult and Nursing Consult, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contacts Kim-Anh Hoang
Elsevier
31-20-485-3634
k.hoang@elsevier.com

Professor Gerry Stimson
Editor-in-Chief, International Journal of Drug Policy
44-7872-600-908
gerry.stimson@gmail.com

ELSE PRESS RELEASES FROM THIS DATE:

Chemical weapon in spider silk repels ant attack: New study

2011-11-23

Researchers have shown for the first time how Golden orb web spiders (Nephila antipodiana) add a chemical to their web silk to repel invading ants. The finding adds a chemical defense to the impressive properties of spider silk, already known to be very strong, elastic and adhesive, and may provide new opportunities for pesticide design. The study was led by researchers from the National University of Singapore (NUS) and the University of Melbourne, and is published in the journal Proceedings of the Royal Society B today [Wednesday, 23 November 2011]. Associate Professor ...

3 researchers in the Amazon clear up doubts as to the benefits of ecotourism

2011-11-23

Ecological tourism has no effect on the presence of large mammals in the Amazon, according to a study that for the first time compares the biological diversity of ecotourism zones with that of protected areas. Furthermore, it can help to protect the biodiversity of areas that are not officially protected yet are vital in the ecological framework. Since the UN began to promote ecological tourism at the end of the 1980's as a way of protecting the environment without resorting to its economic exploitation, the debate as to whether ecotourism is really beneficial has remained ...

TV2 Free for Existing Boxer Subscribers

2011-11-23

Boxer will include TV2 paid channel (in Danish the term is Tv2 betalingskanal) in all of the Boxer TV-packages to ensure subscribers continued access to the channel. "It's great that we have signed the first distribution agreement and that TV2 will remain available to Boxer's customers with aerial reception whether they're watching from their living room or in their summer home and whether the channel is part of a TV-package or purchased separately," says administrative director at TV2, Merete Eldrup. TV2 will be included in the TV packages Boxer MINI, ...

Turkey talk: 2 American Chemical Society videos digest Thanksgiving myth and fact

2011-11-23

WASHINGTON -- Does tryptophan in turkey really cause the bleary-eyed daze after a Thanksgiving meal? What's inside those pop-up timers that announce the turkey is ready for the table? How can those timers pop up when the turkey reaches exactly the right internal temperature? For answers to those and other questions that could spark lively dinnertime conversation Thursday, check out two high-definition Bytesize Science videos that the American Chemical Society (ACS), the world's largest scientific society, is offering as an addition to the holiday menu. They are available ...

Agencies Pursuing Employers who Misclassify Non-Employees in New York

2011-11-23

The Labor Department will be sharing information with nearly a dozen states, including New York's Attorney General, and the Internal Revenue Service in a push to crack down on businesses that cheat workers out of wages by misclassifying them as independent contractors. Wage and hour determinations vary greatly based on how a worker is characterized. By sharing information Labor officials will be able to target businesses that misclassify workers as independent contractors or non-employees to avoid paying the minimum wage and overtime pay. An employer can also avoid paying ...

Robojelly gets an upgrade

2011-11-23

Engineers at Virginia Polytechnic Institute and State University (VirginiaTech) have developed a robot that mimics the graceful motions of jellyfish so precisely that it has been named Robojelly. Developed for the Office of Naval Research in 2009, this vehicle was designed to conduct ocean underwater surveillance, enabling it potentially to detect chemical spills, monitor the presence of ships and submarines, and observe the migration of schools of fish. Recently, a team at VirginiaTech has improved the performance of this silicone swimmer, enabling it to better overcome ...

New design for mechanical heart valves

2011-11-23

The heart's valves, which guarantee the unidirectional flow of blood from one chamber to another, are asymmetrical. For example, the two flaps of the heart's mitral valve – which regulates blood flow between the left atrium and the left ventricle – vary in size by up to 70 percent. This arrangement, says fluid mechanicist Marija Vukicevic from the University of Trieste (now a researcher at Clemson University), naturally drives blood flow along the lateral wall of the ventricle; from there, blood takes a smooth turn creating a large vortex that redirects the blood toward ...

Juvenile Incarceration Costly and Ineffective, Study Says

2011-11-23

Fervent debates continue over how states should rehabilitate juveniles convicted of crimes. Some believe that exposing kids to the rigors of prison life will help them understand the gravity of their actions and prevent future juvenile crime. Others maintain that jailing kids does nothing to deter crime and only advances the likelihood that they will be criminals as adults. Further, they believe that children are more likely to be abused while in confinement. A new report by the Annie E. Casey Foundation exemplifies these concerns. Entitled, "No Place for Kids: ...

A tiny flame shines light on supernovae explosions

2011-11-23

Starting from the behavior of small flames in the laboratory, a team of researchers has gained new insights into the titanic forces that drive Type Ia supernova explosions. These stellar explosions are important tools for studying the evolution of the universe, so a better understanding of how they behave would help answer some of the fundamental questions in astronomy. Type Ia supernovae form when a white dwarf star – the left-over cinder of a star like our Sun – accumulates so much mass from a companion star that it reignites its collapsed stellar furnace and detonates, ...

Peering inside the 'deflagration-to-detonation transition' of explosions

2011-11-23

Explosions of reactive gases and the associated rapid, uncontrolled release of large amounts of energy pose threats of immense destructive power to mining operations, fuel storage facilities, chemical processing plants, and many other industrial applications. To gain a better understanding of what's going on during these explosions, US Naval Research Laboratory research physicist Alexei Poludnenko, and Elaine Oran, senior scientist for reactive flow physics, teamed up with Sandia National Laboratories' Thomas Gardiner, principal member of technical staff, to study the ...

Phase III trial finds hypofractionated radiotherapy with chemotherapy offers comparable survival and lower toxicity to conventional schedule in LS-SCLC

EA5181 phase 3 trial finds no OS benefit for concurrent and consolidative durvalumab vs consolidation alone in unresectable stage 3 NSCLC

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

Drug laws fail to protect children

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: